EGFR and non-small cell lung carcinoma: Conduct an analysis containing data from clinical trials enrolling a sufficient representation of US racial and ethnic minorities, including Black or African American patients, that is reflective of the US population of patients with EGFR exon 20 insertion–mutated NSCLC